ABSTRACT: Buprenorphine is well established history of treatment for chronic pain and addiction management for opioid dependence. While Buprenorphine is an opioid, most providers are not familiar with its use and potential adverse reactions. All providers should be educated in the use of buprenorphine for the management of chronic pain, regardless of the cause. The CDC states while pain management is stepwise approach, with opioids being the last step, adding buprenorphine as a seperate line, may prevent multiple overdose deaths or opioid dependency.
Objective: Change buprenorphine to first line long acting opioid for chronic pain control.
Methods: Pubmed search using keywords, Buprenorphine, opioid ,pain control, written within the last 10 years. CDC pain management guidelines. Comparing prior studies between opioids versus buprenorphine.
Results: Buprenorphine is a safer medication than traditional opioids for the management of chronic pain and clinical practice guidelines should change to include this recommendation. While abuse and overdose is still possible with buprenorphine, this study excludes buprenorphine with naloxone combination medications.
"Buprenorphine, an opioid who’s placement should be the first line choice to chronic pain management with CDC guideline updates.,"
Lynchburg Journal of Medical Science: Vol. 2
, Article 19.
Available at: https://digitalshowcase.lynchburg.edu/dmscjournal/vol2/iss1/19
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.